• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

13.12 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 40
Open 13.12
Bid (Size) 12.00 (100)
Ask (Size) 13.60 (300)
Prev. Close 13.12
Today's Range 13.12 - 13.12
52wk Range 10.70 - 30.78
Shares Outstanding 103,647,871
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
NovoCure (NVCR) Q4 2024 Earnings Call Transcript ↗
December 23, 2025
NovoCure (NVCR) Q4 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
NovoCure (NVCR) Q3 2024 Earnings Call Transcript ↗
December 23, 2025
NovoCure (NVCR) Q3 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings

Performance

YTD
N/A
N/A
1 Month
+8.3%
+8.3%
3 Month
-9.5%
-9.5%
6 Month
-22.3%
-22.3%
1 Year
-55.8%
-55.8%

More News

Read More
News headline image
Novocure (NVCR) Q2 2025 Earnings Call Transcript ↗
December 23, 2025
Via The Motley Fool
Topics Earnings
News headline image
Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference
December 22, 2025
From Novocure
Via Business Wire
News headline image
Earnings Scheduled For October 30, 2025 ↗
October 30, 2025
Via Benzinga
News headline image
Novocure Appoints Company President Frank Leonard as Chief Executive Officer
December 01, 2025
From Novocure
Via Business Wire
News headline image
NovoCure (NVCR) Q3 2025 Earnings Call Transcript ↗
November 27, 2025
Via The Motley Fool
Topics Earnings World Trade
News headline image
Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
November 26, 2025
From Novocure
Via Business Wire
News headline image
2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon ↗
November 12, 2025
Via The Motley Fool
News headline image
Novocure to Participate in 2025 Jefferies Global Healthcare Conference
November 12, 2025
From Novocure
Via Business Wire
News headline image
Novocure (NASDAQ:NVCR) Q3 2025 Earnings: Revenue Beat and Narrower Loss Drive Shares Higher ↗
October 30, 2025
Via Chartmill
News headline image
Novocure Reports Third Quarter 2025 Financial Results
October 30, 2025
From Novocure
Via Business Wire
News headline image
Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress
October 15, 2025
From Novocure
Via Business Wire
News headline image
Novocure to Report Third Quarter 2025 Financial Results
October 01, 2025
From Novocure
Via Business Wire
News headline image
Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields (TTFields) Therapy for Brain Metastases from Non-Small Cell Lung Cancer at 2025 ASTRO Annual Meeting
September 29, 2025
From Novocure
Via Business Wire
News headline image
Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC)
September 15, 2025
From Novocure
Via Business Wire
News headline image
2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts ↗
August 29, 2025
Via The Motley Fool
News headline image
Novocure Announces Upcoming Investor Events
August 28, 2025
From Novocure
Via Business Wire
News headline image
Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain
August 25, 2025
From Novocure
Via Business Wire
News headline image
Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer
August 20, 2025
From Novocure
Via Business Wire
News headline image
Top 3 Health Care Stocks That May Explode In July ↗
July 28, 2025
Via Benzinga
News headline image
NovoCure Q2 Revenue Jumps 6 Percent ↗
July 24, 2025
Via The Motley Fool
Topics World Trade
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
July 24, 2025
Via Benzinga
News headline image
Novocure: Steady Ahead of Key Milestones ↗
July 24, 2025
Via The Motley Fool
News headline image
Novocure Reports Second Quarter 2025 Financial Results
July 24, 2025
From Novocure
Via Business Wire

Frequently Asked Questions

Is NovoCure Limited - Ordinary Shares publicly traded?
Yes, NovoCure Limited - Ordinary Shares is publicly traded.
What exchange does NovoCure Limited - Ordinary Shares trade on?
NovoCure Limited - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for NovoCure Limited - Ordinary Shares?
The ticker symbol for NovoCure Limited - Ordinary Shares is NVCR on the Nasdaq Stock Market
What is the current price of NovoCure Limited - Ordinary Shares?
The current price of NovoCure Limited - Ordinary Shares is 13.12
When was NovoCure Limited - Ordinary Shares last traded?
The last trade of NovoCure Limited - Ordinary Shares was at 01/02/26 04:00 PM ET
What is the market capitalization of NovoCure Limited - Ordinary Shares?
The market capitalization of NovoCure Limited - Ordinary Shares is 1.36B
How many shares of NovoCure Limited - Ordinary Shares are outstanding?
NovoCure Limited - Ordinary Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap